Sep 2026
Discovery of Emodin as a novel competitive KPC-2 inhibitor through virtual screening: Synergistic efficacy with Meropenem against Carbapenem-resistant Klebsiella pneumoniae infection.
Findings suggest that emodin acts as a promising candidate of KPC-2 inhibitor, which is capable of reinstating carbapenem efficacy against carbapenem-resistant Gram-negative pathogens in vitro and in vivo.
Yan Wang, Jia-Min Geng, Bing-Yan Li et al.
· Bioorganic chemistry (Print) · 0 citations